Clinical trial
Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung…
NCT00002887 · Ottawa Regional Cancer Centre, Other · Unknown status
Key facts
| NCT number | NCT00002887 |
|---|---|
| Title | Hydroxyurea Plus Combination Chemotherapy in Patients With Non-small Cell Lung Cancer |
| Official title | PHASE I TRIAL OF HYDROXYUREA FOR SALVAGE OF INCURABLE NON-SMALL CELL LUNG CANCER |
| Lead sponsor | Ottawa Regional Cancer Centre, Other |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Procedure |
| Interventions | cisplatin, etoposide, hydroxyurea, vinblastine sulfate, vindesine, vinorelbine tartrate, drug resistance inhibition treatment |
| Enrollment | 30 |
| Start date | Jul 1, 1995 |
| First posted | Mar 26, 2004 |
| Last update posted | Sep 17, 2013 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: